Sionna Therapeutics annual meeting results: all director nominees elected, auditor ratified

Sionna Therapeutics, Inc.

Four Class II directors elected: H. Edward Fleming, Marcella Kuhlman Ruddy, Peter A. Thompson, Joanne Louise Viney.
Ratification of Deloitte & Touche LLP as independent auditor for FY 2026 approved with 43,291,215 votes for.
Meeting held June 17, 2026; 45,142,330 shares outstanding as of record date April 21, 2026.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sionna Therapeutics, Inc. shareholders approved Election of four Class II directors at the 2026-06-17 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

1. To elect four nominees as Class II directors: H. Edward Fleming, Jr., M.D., Marcella Kuhlman Ruddy, M.D., Peter A. Thompson, M.D., and Joanne Louise Viney, Ph.D., each to hold office until the Company's Annual Meeting of Stockholders in 2029.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sionna Therapeutics, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-17

Exact text from the filing

2. To ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Sionna Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-044263

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.